Social Capital Suvretta
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DNAA and buy or sell other stocks, ETFs, and their options commission-free!About DNAA
Akili, Inc. is a digital medicine company, which engages in the development of cognitive treatments through technologies. Its technologies are designed to directly target the physiology of the brain.
CEOMatthew Franklin, MBA
CEOMatthew Franklin, MBA
Employees—
Employees—
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2020
Founded2020
Employees—
Employees—
DNAA Key Statistics
Market cap448.69M
Market cap448.69M
Price-Earnings ratio-53.78
Price-Earnings ratio-53.78
Dividend yield—
Dividend yield—
Average volume406.74K
Average volume406.74K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$17.44
52 Week high$17.44
52 Week low$9.07
52 Week low$9.07
Stock Snapshot
As of today, Social Capital Suvretta(DNAA) shares are valued at $14.07. The company's market cap stands at 448.69M, with a P/E ratio of -53.78.
On 2025-12-16, Social Capital Suvretta(DNAA) stock opened at —, reached a high of —, and a low of —.
The Social Capital Suvretta(DNAA)'s current trading volume is 0, compared to an average daily volume of 406.74K.
In the last year, Social Capital Suvretta(DNAA) shares hit a 52-week high of $17.44 and a 52-week low of $9.07.
In the last year, Social Capital Suvretta(DNAA) shares hit a 52-week high of $17.44 and a 52-week low of $9.07.
People also own
Based on the portfolios of people who own DNAA. This list is generated using Robinhood data, and it’s not a recommendation.